National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 11/1/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

Eli Lilly and Company;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Teva

Alexion Pharmaceuticals, Inc.;
ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Teva

None

None

5/8/2014

Mojtaba Akhtari, MD

None

None

None

None

5/15/2013

Jessica Altman, MD

ARIAD Pharmaceuticals, Inc.;
Boehringer Ingelheim GmbH;
Bristol-Myers Squibb Company;
Millennium Pharmaceuticals, Inc.;
Agios;
Ambit;
Astellas;
Cyclacel;
Epizyme;
Lilly Pharmaceuticals;
Talon;
Pfizer Inc.

Amgen Inc.;
ARIAD Pharmaceuticals, Inc.;
ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

6/4/2014

Stefan K. Barta, MD, MS, MRCP

Millennium Pharmaceuticals, Inc.;
Kyowa Hakko Kirin;
Optimer;
Otsuka Pharmaceuticals;
Seattle Genetics

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Seattle Genetics;
Seattle Genetics;
Pharmacyclics

None

None

9/24/2014

Ellin Berman, MD

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Ariad Pharmaceuticals

ARIAD Pharmaceuticals, Inc.

None

None

5/23/2014

Marian Birkeland, PhD

None

None

None

None

10/7/2014

Peter Curtin, MD

Onconova

None

None

None

11/21/2013

Daniel J. DeAngelo, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

9/5/2013

Michael Deininger, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Gilead

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

5/1/2014

Steven Devine, MD

Genzyme Corporation

GlaxoSmithKline;
Kiadis;
sanofi-aventis U.S.

None

None

5/22/2014

Fayna Ferkle, PharmD

None

None

None

None

10/14/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

3/21/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

Gabriela Hobbs, MD

None

None

None

None

9/3/2014

Madan Jagasia, MD

None

Therakos, Inc.

None

None

6/5/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/15/2014

Susan O'Brien, MD

Ariad;
Infinity;
Morphosys

Teva

None

None

8/27/2013

Arnel Pallera, MD

None

None

None

None

5/30/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

10/1/2014

Jerald P. Radich, MD

Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Incyte;
Pfizer Inc.

None

None

5/30/2014

Vishnu VB. Reddy, MD

None

None

None

None

10/18/2013

Michal Rose, MD

       

Pending

Neil P. Shah, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company

None

None

None

10/22/2013

B. Douglas Smith, MD

Bristol-Myers Squibb Company;
Merck & Co., Inc.;
CSL-Behring;
Pfizer Inc.

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Incyte

None

None

5/2/2014

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

4/1/2014

Hema Sundar, PhD

None

None

None

None

10/27/2014

Raoul Tibes, MD, PhD

       

Pending

Meir Wetzler, MD

Bristol-Myers Squibb Company;
National Cancer Institute;
Cyclacel;
MedPace;
OSU;
Prime Oncology

Boehringer Ingelheim GmbH;
Clinical Connexion;
Dava;
Envision;
Intellsphere;
McVeigh;
MedLearning;
P4 Healthcare;
Sigma-Tao;
WebMD

None

None

7/30/2014